Sandoz Incorporated FDA Inspection Record

FEI 1717759 · Inspections, Form 483s, warning letters and import refusals

Sandoz Incorporated is an FDA-inspected facility (FEI 1717759) located in East Hanover, NJ, US. RegDataLab tracks 8 FDA inspections and 1 compliance action at this facility.

What FDA found at this site

Latest inspection
Apr 16, 2019: Voluntary Action Indicated (VAI)
Inspections on record
8 (1 OAI, 6 VAI, 1 NAI)
Last OAI inspection
May 6, 2011
Warning letters
1 listed by FDA for this FEI, latest Nov 18, 2011
Form 483 and inspection documents
1 in FDA's reading room
Recalls as the recalling firm
35, latest Apr 6, 2018
Import refusals
7

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Newest first. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
Apr 16, 2019Voluntary Action Indicated (VAI)Cleaning / Sanitizing / Maintenance (21 CFR 211.67(a))
Lab controls established, including changes (21 CFR 211.160(a))
Investigations of discrepancies, failures (21 CFR 211.192)
Mar 29, 2017No Action Indicated (NAI)No citations listed
Oct 30, 2015Voluntary Action Indicated (VAI)No citations listed
Oct 17, 2013Voluntary Action Indicated (VAI)Written procedures fail to include (21 CFR 211.67(b))
Written record of investigation incomplete (21 CFR 211.192)
Late submission of 15-day report (21 CFR 314.80(c)(1)(i))
Aug 14, 2012Voluntary Action Indicated (VAI)No citations listed
May 6, 2011Official Action Indicated (OAI)Authority lacking to review records, investigate errors (21 CFR 211.22(a))
Equipment Design, Size and Location (21 CFR 211.63)
Cleaning / Sanitizing / Maintenance (21 CFR 211.67(a))
Rotation of components/containers/closures (21 CFR 211.86)
and 7 more
May 28, 2010Voluntary Action Indicated (VAI)No citations listed
Oct 8, 2008Voluntary Action Indicated (VAI)Late submission of 15-day report (21 CFR 314.80(c)(1)(i))

Recalls

Showing the 10 most recent of 35 recalls. Recalls FDA's Enforcement Report lists with this FEI as the recalling firm. The recalling firm is not always the site that made the product. Search FDA's Enforcement Report by recall number.

DateClassRecallProduct and reason
Apr 6, 2018Class IIID-0631-2018Triamterene and Hydrochlorothiazide Tablets, USP, 75 mg/50 mg, 500-count bottles, Rx only…
Cross Contamination With Other Products: presence of unrelated ingredients (i.e. traces of Lisinopril, Mannitol, Iron, Calcium and…
Jun 16, 2017Class IIID-0943-2017Amitriptyline HCl Tablets, USP 25 mg, Packaged in a)100-count bottles (NDC 0781-1487-01)…
Cross Contamination With Other Product: Imipramine
Dec 22, 2016Class IID-0236-2017Nadolol Tablets, USP, 40mg, packaged in 1000-count bottle, Rx Only, Manufactured by Sandoz…
Failed dissolution specification: recalled due to an out of specification dissolution result of 40% (Specification: NLT 80%)
Dec 5, 2014Class IIID-0291-2015Fluoxetine Capsules USP, 20 mg, 100 count bottle, Rx Only, 100 Capsules, Sandoz Inc…
Labeling: Illegible Label: Sandoz Inc. is recalling of one lot of Fluoxetine Capsules due to an illegible logo on the capsule.
Jul 25, 2014Class IID-1509-2014Alprazolam Tablets, USP, 0.25mg, Rx only, 1000 tablets, Sandoz Inc., Princeton, NJ --- NDC…
Presence of Foreign Substance; tablets may contain stainless steel metal particulates
Oct 22, 2013Class IID-383-2014Tacrolimus Capsules, USP, 0.5 mg, 100 capsules/bottle, Rx only, Manufactured in India by…
Cross Contamination with Other Products: findings of carryover of trace amounts of a previously manufactured product fluvastatin
Sep 25, 2013Class IIID-66373-001Hydroxychloroquine Sulfate Tablets, USP, 200 mg, Rx Only, 100 Tablets per bottle, Sandoz…
Failed Tablet/Capsule Specifications: Sandoz is recalling one lot of Hydroxychloroquine Sulfate Tablets, USP, 200mg, due to illegibility of…
Aug 7, 2013Class IIID-854-2013Introvale (levonorgestrel and ethinyl estradiol) tablets, USP, 0.15 mg/0.03 mg, packaged…
Contraceptive tablets out of sequence: Contraceptive tablets out of sequence: Introvale (levonorgestrel and ethinyl estradiol tablets USP…
Jun 21, 2013Class IID-805-2013Estarylla (Norgestimate and Ethinyl Estradiol) Tablets. USP, 0.25mg/0.035mg, 3X28 tablets…
Contraceptive Tablets out of Sequence: A placebo tablet was found in a row of active tablets.
May 30, 2013Class IID-597-2013Cefazolin, injection, 1 gram per vial, 25 vials per box, sterile, Rx only, single-use…
Lack of Assurance of Sterility: Sandoz Inc is recalling Cefazolin for Injection, USP 1 gm vials, lot DB2208, due to a customer complaint for…

Form 483s and inspection documents

  • 483 on FDA.gov
    FDA listing date Jul 17, 2015, which is not always the inspection or issue date. Published by FDA Jan 18, 2024.

FDA record score

3 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.

Counted on Nov 16, 2026, method version 1. It counts records and does not judge the site: a low number does not establish that a site is safe, and sites that FDA inspects more often can collect more points. How this is counted.

23 records behind this number
RecordDatePoints x age weightAdds
Inspection classified VAIApr 16, 20196 x 0.251.5
Class II recall D-0236-2017, this FEI as the recalling firmDec 22, 20164 x 0.251
Inspection classified VAIOct 30, 201510 years or older, so it adds no points0
Class II recall D-1509-2014, this FEI as the recalling firmJul 25, 201410 years or older, so it adds no points0
Class II recall D-383-2014, this FEI as the recalling firmOct 22, 201310 years or older, so it adds no points0
Inspection classified VAIOct 17, 201310 years or older, so it adds no points0
Class II recall D-805-2013, this FEI as the recalling firmJun 21, 201310 years or older, so it adds no points0
Class II recall D-597-2013, this FEI as the recalling firmMay 30, 201310 years or older, so it adds no points0
Class I recall D-832-2013, this FEI as the recalling firmMay 20, 201310 years or older, so it adds no points0
Class II recall V-146-2013, this FEI as the recalling firmApr 22, 201310 years or older, so it adds no points0
Class II recall D-268-2013, this FEI as the recalling firmApr 18, 201310 years or older, so it adds no points0
Inspection classified VAIAug 14, 201210 years or older, so it adds no points0
Class II recall D-1249-2012, this FEI as the recalling firmJan 31, 201210 years or older, so it adds no points0
Class II recall D-1170-2012, this FEI as the recalling firmJan 6, 201210 years or older, so it adds no points0
Warning letter on FDA's dashboard, which does not show close-outsNov 18, 201110 years or older, so it adds no points0
Inspection classified OAIMay 6, 201110 years or older, so it adds no points0
Class II recall D-162-2011, this FEI as the recalling firmNov 18, 201010 years or older, so it adds no points0
Class II recall D-204-2011, this FEI as the recalling firmNov 18, 201010 years or older, so it adds no points0
Class II recall D-413-2011, this FEI as the recalling firmNov 10, 201010 years or older, so it adds no points0
Class I recall D-130-2011, this FEI as the recalling firmOct 25, 201010 years or older, so it adds no points0
Class II recall D-020-2011, this FEI as the recalling firmSep 24, 201010 years or older, so it adds no points0
Inspection classified VAIMay 28, 201010 years or older, so it adds no points0
Inspection classified VAIOct 8, 200810 years or older, so it adds no points0

When each source was last refreshed

FDA sources behind this page and when RegDataLab last refreshed each one
RecordsLast refreshedSource as ofStatus
InspectionsNov 16, 2026Newest record Nov 5, 2026Current
Inspection citationsNov 16, 2026Newest record Nov 5, 2026Current
Compliance actions (warning letters, injunctions and other action types)Nov 2, 2026Newest record Oct 29, 2026Current
Warning letter textNov 16, 2026Newest record Nov 10, 2026Current
Recalls (Enforcement Report)Nov 16, 2026Newest record Nov 11, 2026Current
Form 483s and inspection documentsNov 13, 2026Newest record Nov 12, 2026Current
Import refusalsNov 15, 2026Newest record Nov 5, 2026Current

Reviewing Sandoz Incorporated as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Sandoz Incorporated yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Facility details

Company
Sandoz Incorporated
Location
East Hanover, NJ (US)
Source
inspections

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.